A study published October 1 in the American Journal of Psychiatry by researchers at Mount Sinai has identified three white matter pathways in the brain that are consistently associated with lasting improvement in patients receiving deep brain stimulation (DBS) for severe, treatment-resistant depression. The findings highlight that the precise targeting of these connections through electrode placement could be critical for successful treatment, with millimeters in positioning potentially determining outcomes.
organisation
Mount Sinai
Hospital and medical research institution in New York City